| 1 |
卫生部十年百项项目专家组. 急性期脑卒中的规范化治疗技术方案应用与推广(节选): 急性期的特殊治疗 [J/CD]. 中华脑血管病杂志(电子版), 2010, 4(2): 130-142.
|
| 2 |
Jager KJ, Kovesdy C, Langham R, et al. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases [J]. Kidney Int, 2019, 96(5): 1048-1050.
|
| 3 |
Harrington JS, Ryter SW, Plataki M, et al. Mitochondria in health, disease, and aging [J]. Physiol Rev, 2023, 103(4): 2349-2422.
|
| 4 |
Liu Y, Huang Y, Xu C, et al. Mitochondrial dysfunction and therapeutic perspectives in cardiovascular diseases [J]. Int J Mol Sci, 2022, 23(24): 16053.
|
| 5 |
Ho HJ, Shirakawa H. Oxidative stress and mitochondrial dysfunction in chronic kidney disease [J]. Cells, 2022, 12(1): 88.
|
| 6 |
Shademan B, Avci CB, Karamad V, et al. The role of mitochondrial biogenesis in ischemic stroke [J]. J Integr Neurosci, 2023, 22(4): 88.
|
| 7 |
Huang H, Oo TT, Apaijai N, et al. An updated review of mitochondrial transplantation as a potential therapeutic strategy against cerebral ischemia and cerebral ischemia/reperfusion injury [J]. Mol Neurobiol, 2023, 60(4): 1865-1883.
|
| 8 |
Fontecha-barriuso M, Martin-sanchez D, Martinez-moreno JM, et al. The role of PGC-1α and mitochondrial biogenesis in kidney diseases [J]. Biomolecules, 2020, 10(2): 347.
|
| 9 |
Fontecha-Barriuso M, Lopez-Diaz AM, Guerrero-Mauvecin J, et al. Tubular mitochondrial dysfunction, oxidative stress, and progression of chronic kidney disease [J]. Antioxidants, 2022, 11(7): 1356.
|
| 10 |
Wei Z, Chong H, Jiang Q, et al. Smooth muscle overexpression of PGC1α attenuates atherosclerosis in rabbits [J]. Circ Res, 2021, 129(4): e72-e86.
|
| 11 |
Stein S, Lohmann C, Handschin C, et al. ApoE−/− PGC-1α −/− mice display reduced IL-18 levels and do not develop enhanced atherosclerosis [J]. PLoS One, 2010, 5(10): e13539.
|
| 12 |
Oller J, Gabandé-Rodríguez E, Ruiz-Rodrígue MJ, et al. Extracellular tuning of mitochondrial respiration leads to aortic aneurysm [J]. Circulation, 2021, 143(21): 2091-2109.
|
| 13 |
Forte M, Schirone L, Ameri P, et al. The role of mitochondrial dynamics in cardiovascular diseases [J]. Br J Pharmacol, 2021, 178(10): 2060-2076.
|
| 14 |
Song M, Mihara K, Chen Y, et al. Mitochondrial fifission and fusion factors reciprocally orchestrate mitophagic culling in mouse hearts and cultured fifibroblasts [J]. Cell Metab, 2015, 21(2): 273-286.
|
| 15 |
Marin W, Marin D, Ao X, et al. Mitochondria as a therapeutic target for cardiac ischemia-reperfusion injury [J]. Mol Med, 2021, 47(2): 485-499.
|
| 16 |
Quan Y, Xin Y, Tian G, et al. Mitochondrial ROS-modulated mtDNA: a potential target for cardiac aging [J]. Oxid Med Cell Longev, 2020, 2020: 9423593.
|
| 17 |
Karnewar S, Pulipaka S, Katta S, et al. Mitochondria-targeted esculetin mitigates atherosclerosis in the setting of aging via the modulation of SIRT1-mediated vascular cell senescence and mitochondrial function in Apoe−/− mice [J]. Atherosclerosis, 2022, 356: 28-40.
|
| 18 |
Kubli DA, Zhang X, Lee Y, et al. Parkin protein defificiency exacerbates cardiac injury and reduces survival following myocardial infarction [J]. J Biol Chem, 2013, 288(2): 915-926.
|
| 19 |
Lu W, Sun J, Yoon JS, et al. Mitochondrial protein PGAM5 regulates mitophagic protection against cell necroptosis [J]. PLoS One, 2016, 11(1): e147792.
|
| 20 |
Tyrrell DJ, Blin MG, Song J, et al. Age-associated mitochondrial dysfunction accelerates atherogenesis [J]. Circ Res, 2020, 126(3): 298-314.
|
| 21 |
Li P, Bai Y, Zhao X, et al. NR4A1 contributes to high-fat associated endothelial dysfunction by promoting CaMKII-Parkin-mitophagy pathways [J]. Cell Stress Chaperones, 2018, 23(4): 749-761.
|
| 22 |
Lai Y, Lin P, Chen M, et al. Restoration of L-OPA1 alleviates acute ischemic stroke injury in rats via inhibiting neuronal apoptosis and preserving mitochondrial function [J]. Redox Biol, 2020, 34: 101503.
|
| 23 |
张业昊, 丛伟红, 刘建勋. 西红花苷对缺氧复氧损伤的SHSY5Y细胞线粒体动力学的影响 [J]. 中国药理学通报, 2016, 32(7): 986-990.
|
| 24 |
Huang J, Chen L, Yao ZM, et al. The role of mitochondrial dynamics in cerebral ischemia-reperfusion injury [J]. Biomed Pharmacother, 2023, 162: 114671.
|
| 25 |
Li J, Wu J, Zhou X, et al. Targeting neuronal mitophagy in ischemic stroke: an update [J]. Burns Trauma, 2023, 11: tkad018.
|
| 26 |
Tuo QZ, Zhang ST, Lei P. Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications [J]. Med Res Rev, 2022, 42(1): 259-305.
|
| 27 |
关瑞桥, 邹伟, 孙晓伟, 等. 线粒体自噬在缺血性卒中的机制研究与展望 [J]. 中国卒中杂志, 2017, 12(8): 748-752.
|
| 28 |
Koh E, Kim YK, Shin D, et al. MPC1 is essential for PGC-1α-induced mitochondrial respiration and biogenesis [J]. Biochem J, 2018, 475(10): 1687-1699.
|
| 29 |
Fontecha-Barriuso M, Martín-Sánchez D, Martinez-Moreno JM, et al. PGC-1α defificiency causes spontaneous kidney inflflammation and increases the severity of nephrotoxic AKI [J]. Pathol, 2019, 249(1): 65-78.
|
| 30 |
Wang Y, Liu Q, Cai J, et al. Emodin prevents renal ischemiareperfusion injury via suppression of CAMKII/DRP1-mediated mitochondrial fifission [J]. Eur J Pharmacol, 2022, 916: 174603.
|
| 31 |
Wang Y, Lu M, Xiong L, et al. Drp1-mediated mitochondrial fifission promotes renal fifibroblast activation and fifibrogenesis [J]. Cell Death Dis, 2020, 11(1): 29.
|
| 32 |
Li S, Lin Q, Shao X, et al. Drp1-regulated PARK2-dependent mitophagy protects against renal fifibrosis in unilateral ureteral obstruction [J]. Free Radic Biol Med, 2020, 152: 632-649.
|
| 33 |
Tagaya M, Kume S, Yasuda-Yamahara M, et al. Inhibition of mitochondrial fifission protects podocytes from albumin-induced cell damage in diabetic kidney disease [J]. Biochim Biophys Acta Mol Basis Dis, 2022, 1868(5): 166368.
|
| 34 |
Qin X, Zhao Y, Gong J, et al. Berberine protects glomerular podocytes via inhibiting drp1-mediated mitochondrial fission and dysfunction [J]. Theranostics, 2019, 9(6): 1698-1713.
|
| 35 |
Aparicio-Trejo OE, Avila-Rojas SH, Tapia E, et al. Chronic impairment of mitochondrial bioenergetics and β-oxidation promotes experimental AKI-to-CKD transition induced by folic acid [J]. Free Radic Biol Med, 2020, 154: 18-32.
|
| 36 |
Gong X, Duan Y, Zheng J, et al. Tetramethylpyrazine prevents contrast-induced nephropathy via modulating tubular cell mitophagy and suppressing mitochondrial fragmentation, CCL2/CCR2-mediated inflflammation, and intestinal injury [J]. Oxid Med Cell Longev, 2019, 2019: 7096912.
|
| 37 |
Yao M, Liu Y, Sun M, et al. The molecular mechanisms and intervention strategies of mitophagy in cardiorenal syndrome [J]. Front Physiol, 2022, 13: 1008517.
|
| 38 |
Bhatia D, Chung KP, Nakahira K, et al. Mitophagy-dependent macrophage reprogramming protects against kidney fifibrosis [J]. JCI Insight, 2019, 4(23): e132826.
|
| 39 |
Wang Y, Tang C, Cai J, et al. PINK1/Parkin-mediated mitophagy is activated in cisplatin nephrotoxicity to protect against kidney injury [J]. Cell Death Dis, 2018, 9(11): 1113.
|
| 40 |
Kawakami T, Gomez IG, Ren S, et al. Defificient autophagy results in mitochondrial dysfunction and FSGS [J]. Am Soc Nephrol, 2015, 26(5): 1040-1052.
|
| 41 |
Cui J, Shi S, Sun X, et al. Mitochondrial autophagy involving renal injury and aging is modulated by caloric intake in aged rat kidneys [J]. PLoS One, 2013, 8(7): e69720.
|
| 42 |
Han P, Yuan C, Wang Y, et al. Niclosamide ethanolamine protects kidney in adriamycin nephropathy by regulating mitochondrial redox balance [J]. Am J Transl Res, 2019, 11(2): 855-864.
|